Inner Balance

The team page names individual clinicians: Sarah Daccarett, MD, Barry Aron, MD, and Bridgette Baker, MD, alongside nursing and other clinical staff. These are the service’s stated titles and credentials, rather than an independent license verification. The consent describes providers contracted with Inner Balance and a clinical team working together. That is different from a promise that the founder will personally manage every prescription. Ask who will assess you and which clinician handles later treatment questions. The NAD+ page describes a U.S. 503A compounding pharmacy without giving the dispensing pharmacy’s name.

You complete an online intake covering health goals, medical history and lifestyle. A licensed provider decides whether the proposed prescription is appropriate. The NAD+ page says no laboratory tests or appointments are required upfront. Its plan includes ongoing telehealth access, while both relevant product pages advertise unlimited clinical follow-up. The public material does not establish a mandatory live visit, a guaranteed response time or continuity with one individual clinician. The consent allows different forms of remote communication. Ask how side effects and treatment changes reach a prescriber, rather than assuming general customer service can make clinical decisions.

The NAD+ intake description says no labs are required upfront. That is a statement about entry to this program, not proof that laboratory testing will never be appropriate. The general FAQ’s discussion of hormone testing concerns Oestra and should not be treated as a universal NAD+ or Libida protocol. A peptide-specific additional laboratory price is not established. Bring relevant existing diagnoses and medication information to the clinician rather than relying on a product quiz as a complete medical assessment.